Results for “ ”

Entry Author Date Location
Tobira Fails Main Goal in NASH Study, But Forges Ahead To Next Trial 07/25/16 San Francisco
Biotech Roundup: Scangos’s Exit, Zafgen’s Shakeup, Jounce, Relypsa & More 07/22/16 National
Indigo’s Microbial Tech for Crops Lands $100M to Fight Plant Stresses 07/21/16 Boston
With Biogen at a Crossroads, CEO Scangos to Step Down 07/21/16 Boston
Audentes Prices $75M IPO As Gene Therapy Eyes First U.S. Approval 07/20/16 San Francisco
Merck, Amgen Invest in Akili as Therapeutic Video Game Moves Ahead 07/20/16 Boston
Synthorx Raises $10M to Expand Use of Synthetic DNA in Biologics 07/20/16 San Diego
Zafgen Restructures, Abandons Obesity Drug Following FDA Meeting 07/19/16 Boston
Oncorus Bags $57M, Touts Next-Gen Take on Cancer-Fighting Viruses 07/19/16 Boston
With Celgene Deal, Jounce Lands $261M And a “Trusting Partner” 07/19/16 Boston
Ex-Epizyme CEO’s New Startup, Fulcrum, Nabs $55M For Gene Control Drugs 07/19/16 Boston
Ziopharm Discloses Patient Death in Brain Cancer Trial, Shares Fall 07/15/16 Boston
Biotech Roundup: Hellos, Goodbyes, “Cures” Delays And Trial News 07/15/16 National
Sarepta Stock Down as FDA Seeks More Data from Rival Duchenne Drug 07/14/16 Boston
No Profits, No Problem: Imprivata Bought by Private Equity for $544M 07/13/16 Boston
Caveats But No “Quicksand” In Sage’s Positive Postpartum Trial Data 07/12/16 Boston
With Bugs As Drugs, Evelo CEO Plans Immune, Cancer Trials in 2017 07/12/16 Boston
With Positive Postpartum Results, Sage Ponders More Mood Disorders 07/12/16 Boston
An Homage to Larry Bock, Who Had God’s Hand on His Shoulder 07/11/16 San Diego
Tesaro Stock Sale Hauls in $409M on Heels of Strong Cancer Data 07/08/16 Boston
Eleven Bio’s Eye Disease Drug Set For $22.5M Milestone from Roche 07/08/16 Boston
Biotech Roundup: Fighting Addiction, Obama Precision, Juno Deaths & More 07/08/16 National
Recruitment Goal In Obama Precision Med Study: 1M in 3 or 4 Years 07/06/16 National
Pfizer Might Buy Bind Therapeutics From Bankruptcy for $20M 07/06/16 Boston
With CF Pact, Moderna and Vertex Aim to Spray mRNA Into the Lungs 07/06/16 Boston
Alnylam Advances RNAi Drug Results After Two Years of Treatment 07/01/16 Boston
Biotech Roundup: Moonshots, Pink Slips, Gilead, Brexit & More 07/01/16 National
Riding Moonshot, FDA Will Revamp Its Cancer Practice. To What End? 06/30/16 National
Harvard’s Springer Gets $51.5M From Pharmas, Others, For Latest Startup 06/30/16 Boston
Syros Cuts Price But Bags $50M in IPO to Fuel Cancer Drug Trials 06/29/16 Boston
Page 1 of 287 next page »